Make sure you meet with us and discuss your projects and demands as well as new developments and service opportunities in person!

Please contact Luca Covello to arrange a meeting prior to the show.

Forthcoming Events

  • CPhI North America, May 16-18, 2017 Pennsylvania Convention Center Philadelphia, PA, USA (BOOTH 2253)
  • CF@BO 2017, June 4-6, 2017 Bologna, Italy
  • CPhI Worldwide, 24 - 26 October 2017 Messe Frankfurt, Germany  (STAND No: 40B40)

order by visits date title

Polymorphs of Dex-Lansoprazole

  New Crystalline Forms of Dex-Lansoprazole Discovered PolyCrystalLine s.r.l. and Segrub Pharmaceuticals have developed a generic equivalent to Kapidex (dexlansoprazole). This DEP002 product contains a new and stable crystal of dexlansoprazole which circumvents Takeda’s intellectual property. Kapidex is a proton pump inhibitor that obtained FDA approval in 2009 by Takeda Pharmaceuticals for the treatment of heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GE

Read all

Pagina 2 di 2
© Copyright Polycrystalline SpA - All rights reserved - VAT IT02600021204 / powered by DibiWeb